Who we are
We are parents, individuals, care providers, and loved ones of those with insulin-dependent diabetes. We are volunteering our time to protect insulin options to ensure patients have access to the life-saving medication that best serves them.
Our goals
This quest to slow the Levemir discontinuation until after a biosimilar is widely available rests largely on an upcoming Senate HELP Committee Hearing on September 24, 20024 in Washington DC.
Update
We believe everyone who uses insulin as a life saving therapy should have access to the insulin of their choice - the insulin that serves them best. Learn more about our current campaign.